KEEP Intervention for People Newly Diagnosed With Parkinson's (KEEP)
1 de novembro de 2022 atualizado por: Ledia Alushi, University of Cambridge
KEEP- A Randomised Feasibility Study of a Co-designed Physical Health Education Intervention to Improve Knowledge, Exercise Efficacy and Participation for Newly Diagnosed People With Parkinson's.
Parkinson's Disease (PD) is a progressive neurological condition that affects movement, balance and cognition, resulting in loss of independence and compromised quality of life over the course of the condition. Research suggests that those detrimental outcomes can be reduced through physical activity (PA) and exercise, especially when those are started early. Educating people with Parkinson's (PwP) on the role of PA and exercise in PD progression can boost PA engagement by increasing enablers such as exercise self-efficacy and removing barriers such as misinformation about exercise and exercise outcomes.
Working closely with PwP and healthcare professionals, a physical health education programme was co-designed to address the needs and preferences of PwP around exercise and PA education. The process was supervised by the patient and Public Involvement group attended by PwP, academics, researchers and clinicians working with PwP.
The study will utilise an assessor blinded randomised controlled design to investigate the acceptability and feasibility of delivering an online physical health education programme for PwP who are newly diagnosed. Thirty PwP, diagnosed in the last 12-months, will be randomly allocated into two groups: 1) the intervention group in which participants will receive online education modules and will be invited to attend virtual group sessions with a specialist neuro-physiotherapist; 2) the control group which will follow the usual care pathway and participants will receive Parkinson's UK booklets.
The aim of the study is to explore an alternative approach to standard care regarding patient education in PD and evaluate the feasibility and acceptability of a co-designed education intervention for newly diagnosed PwP delivered online. Feasibility data will be collected during the study and acceptability data will be assessed via a questionnaire at the end. Outcomes including PA levels, exercise knowledge, exercise efficacy, and participation will be assessed at baseline, post-intervention and at 6 months.
Visão geral do estudo
Status
Ativo, não recrutando
Condições
Intervenção / Tratamento
Tipo de estudo
Intervencional
Inscrição (Real)
30
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
-
Cambridge, Reino Unido, CB2 0SZ
- Department of Psychiatry
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
18 anos e mais velhos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- Clinical diagnosis of Idiopathic Parkinson's Disease
- Within 12 months since diagnosis
- Stable medication regime for four weeks prior to initiation of trial
- Ability to understand written English
Exclusion Criteria:
- Acute illness
- History of neurological disorder other than Parkinson Disease
- Diagnosis of dementia or significant cognitive impairments
- Participation in NHS structured PD-specific education program with or without exercise classes in the last year
- Unable to understand written English
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Intervention group
The experimental group will receive: Online education modules Online group discussions facilitated by Specialist Physiotherapist |
Educational intervention
|
|
Comparador Ativo: Control Group
The comparator for this study is usual care pathway.
Under the usual care pathway, participants will receive education booklets on exercise by Parkinson's UK.
|
booklet from Parkinson's UK
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Acceptability assessment 1: Recruitment rate
Prazo: Through study completion (12 months)
|
Assessment of recruitment rate of study (% of eligible participants enrolled)
|
Through study completion (12 months)
|
|
Acceptability assessment 2: Education programme compliance
Prazo: Through study completion (12 months)
|
Compliance with the online education programme (% of sessions completed)
|
Through study completion (12 months)
|
|
Acceptability assessment 3: Drop out rate
Prazo: Through study completion (12 months)
|
Comparison of drop out rates (%) between the intervention group and control group
|
Through study completion (12 months)
|
|
Acceptability assessment 4: Acceptability of Intervention
Prazo: Completed at the end of participation in the study (after 8 weeks)
|
A questionnaire designed to assess satisfaction with the education intervention.
it includes multiple choice and open ended questions.
|
Completed at the end of participation in the study (after 8 weeks)
|
|
Feasibility of delivering the intervention online
Prazo: Through study completion (12 months)
|
Assessment of any technical problems or difficulties accessing online intervention as reported by participants
|
Through study completion (12 months)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Unified Parkinson's Disease Rating Scale Part 3
Prazo: Baseline(week 0) and follow up (6-month post intervention)
|
The UPDRS is the gold-standard scale for Parkinson's assessment and has four parts.
For this study only UPDRS III, motor examination will be completed by a trained assessor.
UPDRS III total scores range from 7 to 86 points, with higher scores indicating more severe impairment..
|
Baseline(week 0) and follow up (6-month post intervention)
|
|
MiniBESTest
Prazo: Baseline(week 0) and follow up (6-month post intervention)
|
The Mini-BEST is a 14-item scale that assesses dynamic balance components including anticipatory postural adjustments, reactive postural control, sensory orientation and dynamic gait.
The data is based on a total score of 28 points, with higher score indicating better task performance.
|
Baseline(week 0) and follow up (6-month post intervention)
|
|
Five time Sit To Stand
Prazo: Baseline(week 0) and follow up (6-month post intervention)
|
Five time sit to stand is a validated test used to assess functional lower extremity strength, balance and risk falls in older adults.
It has been used in PD population with high interrater and test-retest reliability.
Longer time to complete indicates worse task performance.
|
Baseline(week 0) and follow up (6-month post intervention)
|
|
Self-efficacy for Exercise
Prazo: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
The Self-Efficacy for exercise (SEE) scale is a 9-item validated scale which assesses a person self-efficacy to exercise under different circumstances.
This scale is a modified version of Bandura's Exercise Self-Efficacy Scale and ask participants to rate their perceived exercise efficacy on a scale form 0 meaning not confident at all to 10 meaning very confident.
Higher score indicate higher self-efficacy
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Hospital Anxiety and Depression Scale
Prazo: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Hospital Anxiety and Depression Scale (HADS) is a widely used questionnaire to measure anxiety and depression.
A self-reported brief instrument which includes 14 questions aiming to detect and indicate severity of anxiety and depression.
It has been used before and is a validated and reliable tool to use in Parkinson's population.
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Apathy Evaluation Scale
Prazo: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Apathy Evaluation Scale (AES) is a standardised and validated self-rating instrument to evaluate apathy.
It consists of 18 items that are scored on a 4-point Likert Scale, with highest score indicating more severe apathy
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Multidimensional Outcome Expectation Scale
Prazo: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Outcome expectations about the benefits of regular exercise and PA will be measured by the Multidimensional Outcomes Expectations for Exercise Scale (MOEES).
The MOEES has 15 items that reflect three subdomains of outcome expectations.
The items were rated on a five-point scale from 1 (Strongly disagree) to 5 (Strongly agree) and summed to form the subscale measures of outcome expectations with higher scores reflecting greater beliefs about the benefits of regular exercise and physical activity.
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Oxford Participation and Activities Questionnaire
Prazo: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Oxford Participation and Activities Questionnaire (Ox-PAQ) is a patient-reported outcome measure comprised of 23 items aiming to assess participation and activity in patients with long-term conditions.
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Recent Physical Activity Questionnaire
Prazo: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Physical Activity will be measured subjectively and objectively.
Subjectively it will be measured via the self-reported Recent Physical Activity Questionnaire (RPAQ), which is designed to assess PA in everyday life in the last 4 weeks.
The questionnaire has three sections assessing a range of activities in different domains (around the house, work and recreation).
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Knowledge of Exercise and Physical Activity
Prazo: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Knowledge of Exercise and Physical Activity questionnaire is a 10-item knowledge questionnaire around the role of exercise and physical activity in the management of PD and it has been designed by the PI to assess knowledge levels.
A total score of 10 indicates better knowledge scores.
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
|
Wrist-worn accelerometer
Prazo: Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Objectively, physical activity will be measured with the use of a wrist-worn accelerometer (GeneActiv monitor) over 7 consecutive days.
|
Baseline(week 0), post intervention (week 8) and follow up (6-month post intervention)
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
18 de junho de 2022
Conclusão Primária (Real)
21 de setembro de 2022
Conclusão do estudo (Antecipado)
18 de junho de 2023
Datas de inscrição no estudo
Enviado pela primeira vez
2 de fevereiro de 2022
Enviado pela primeira vez que atendeu aos critérios de CQ
11 de fevereiro de 2022
Primeira postagem (Real)
23 de fevereiro de 2022
Atualizações de registro de estudo
Última Atualização Postada (Real)
4 de novembro de 2022
Última atualização enviada que atendeu aos critérios de controle de qualidade
1 de novembro de 2022
Última verificação
1 de novembro de 2022
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- A096150
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
INDECISO
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .